Efficacy and safety of endocrine therapy after mastectomy in patients with hormone receptor positive breast ductal carcinoma in situ:retrospective cohort study

Nan Niu, Yinan Zhang, Yang Bai, Xin Wang, Shunchao Yan, Dong Song, Hong Xu, Tong Liu, Bin Hua, Yingchao Zhang, Jinchi Liu, Xinbo Qiao, Jiaxiang Liu, Xinyu Zheng, Hongyi Cao, Caigang Liu
doi: https://doi.org/10.1101/2022.10.06.22280792

Article Information

doi 
https://doi.org/10.1101/2022.10.06.22280792
History 
  • October 7, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Nan Niu1,2,3,†,
  2. Yinan Zhang1,2,3,†,
  3. Yang Bai4,†,
  4. Xin Wang5,
  5. Shunchao Yan1,
  6. Dong Song6,
  7. Hong Xu7,
  8. Tong Liu8,
  9. Bin Hua9,
  10. Yingchao Zhang10,
  11. Jinchi Liu1,2,3,
  12. Xinbo Qiao1,2,3,
  13. Jiaxiang Liu5,
  14. Xinyu Zheng11,*,
  15. Hongyi Cao12,* and
  16. Caigang Liu1,2,3,*,†
  1. 1Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China
  2. 2Cancer Stem Cell and Translational Medicine Laboratory, Shengjing Hospital of China Medical University, Shenyang, China
  3. 3Innovative Cancer Drug Research and Development Engineering Center of Liaoning Province, Shenyang, China
  4. 4Department of Nursing, Shengjing Hospital of China Medical University, Shenyang 110004, China
  5. 5Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  6. 6Department of Breast Surgery, the First Hospital of Jilin University, Changchun, China
  7. 7Department of Breast Surgery, Liaoning Cancer Hospital and Institute, Cancer Hospital of China Medical University, Shenyang, China
  8. 8Department of Breast Surgery, Cancer Hospital of Harbin Medical University, Harbin, China
  9. 9Department of General Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China
  10. 10Department of Breast Surgery, the Second Hospital of Jilin University, Changchun, China
  11. 11Department of Breast Surgery, the First Affiliated Hospital of China Medical University, Shenyang, China
  12. 12Department of Pathology, the First Affiliated Hospital of China Medical University and College of Basic Medical Sciences, Shenyang, China
  1. ↵†Correspondence
    Corresponding Author Caigang Liu, MD, PhD, Department of Oncology, Shengjing Hospital of China Medical University, Shenyang 110004, China, Tel.: 86-18940254967, E-mail: liucg{at}sj-hospital.org
  2. ↵*Co-corresponding authors
Back to top
Posted October 07, 2022.
Download PDF
Data/Code
Email
Efficacy and safety of endocrine therapy after mastectomy in patients with hormone receptor positive breast ductal carcinoma in situ:retrospective cohort study
Nan Niu, Yinan Zhang, Yang Bai, Xin Wang, Shunchao Yan, Dong Song, Hong Xu, Tong Liu, Bin Hua, Yingchao Zhang, Jinchi Liu, Xinbo Qiao, Jiaxiang Liu, Xinyu Zheng, Hongyi Cao, Caigang Liu
medRxiv 2022.10.06.22280792; doi: https://doi.org/10.1101/2022.10.06.22280792
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area